Table 4 Effect of agaro-oligosaccharides on GSH-Px activity in different organs of CCl4 induced rats a
From: Antioxidant activity and hepatoprotective potential of agaro-oligosaccharides in vitro and in vivo
Groups | Liver (NU/mgprot) | Heart (NU/mgprot) | Serum (× 103 NU) |
|---|---|---|---|
Normal control | 159.17 ± 6.97 | 200.20 ± 15.46 | 12.50 ± 1.44 |
CCl4 control | 91.60 ± 3.97# | 191.81 ± 36.90 | 10.38 ± 1.48# |
Vitamin C | 119.41 ± 9.86 | 204.86 ± 17.11 | 11.02 ± 0.66 |
G4 (200 mg/kg) | 120.50 ± 17.05 | 203.63 ± 25.01 | 12.18 ± 1.95 |
G5 (400 mg/kg) | 127.19 ± 12.17* | 217.40 ± 10.82 | 13.13 ± 1.21 |
G6 (600 mg/kg) | 118.92 ± 17.56 | 248.47 ± 39.28 | 12.26 ± 1.30 |